Citation: Am. Sullivan et al., LONG-TERM PROTECTION OF THE RAT NIGROSTRIATAL DOPAMINERGIC SYSTEM BY GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR AGAINST 6-HYDROXYDOPAMINE IN-VIVO, European journal of neuroscience, 10(1), 1998, pp. 57-63
Citation: Rb. Banati et al., GLIAL PATHOLOGY BUT ABSENCE OF APOPTOTIC NIGRAL NEURONS IN LONG-STANDING PARKINSONS-DISEASE, Movement disorders, 13(2), 1998, pp. 221-227
Citation: J. Opackajuffry et al., EFFECTS OF PERGOLIDE TREATMENT ON IN-VIVO HYDROXYL FREE-RADICAL FORMATION DURING INFUSION OF 6-HYDROXYDOPAMINE IN RAT STRIATUM, Brain research, 810(1-2), 1998, pp. 27-33
Authors:
SULLIVAN AM
OPACKAJUFFRY J
HOTTEN G
POHL J
BLUNT SB
Citation: Am. Sullivan et al., GROWTH DIFFERENTIATION FACTOR-5 PROTECTS NIGROSTRIATAL DOPAMINERGIC-NEURONS IN A RAT MODEL OF PARKINSONS-DISEASE/, Neuroscience letters, 233(2-3), 1997, pp. 73-76
Authors:
OPACKAJUFFRY J
ASHWORTH S
SULLIVAN AM
BANATI RB
BLUNT SB
Citation: J. Opackajuffry et al., LACK OF PERMANENT NIGROSTRIATAL DOPAMINE DEFICIT FOLLOWING 6-HYDROXYDOPAMINE INJECTION INTO THE RAT STRIATUM - SHORT COMMUNICATION, Journal of neural transmission, 103(12), 1996, pp. 1429-1434
Authors:
OPACKAJUFFRY J
ASHWORTH S
HUME SP
MARTIN D
BROOKS DJ
BLUNT SB
Citation: J. Opackajuffry et al., GDNF PROTECTS AGAINST 6-OHDA NIGROSTRIATAL LESION - IN-VIVO STUDY WITH MICRODIALYSIS AND PET, NeuroReport, 7(1), 1995, pp. 348-352
Authors:
BLUNT SB
BOULTON J
WISE R
KENNARD C
LEWIS PD
Citation: Sb. Blunt et al., LOCKED-IN SYNDROME IN FULMINANT DEMYELINATING DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 57(4), 1994, pp. 504-505